Company research / AZTR

Azitra, Inc. (AZTR)

CIK 0001701478 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Azitra, Inc. reported revenue of $0. Revenue fell 100.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

-288.2%
Return on year-end equity
-100.0%
Revenue growth (YoY)

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.